TRV GP III, LLC - Q1 2021 holdings

$791 Million is the total value of TRV GP III, LLC's 7 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 28.6% .

 Value Shares↓ Weighting
RVMD SellREVOLUTION MEDICINES, INC.$253,443,000
-8.9%
5,524,031
-21.4%
32.06%
+34.2%
PLRX  PLIANT THERAPEUTICS, INC.$229,654,000
+73.1%
5,839,1600.0%29.05%
+154.9%
NRIX SellNURIX THERAPEUTICS, INC.$140,164,000
-21.4%
4,508,333
-16.9%
17.73%
+15.8%
FULC  FULCRUM THERAPEUTICS, INC.$70,235,000
+0.6%
5,962,2020.0%8.88%
+48.2%
DBTX NewDECIBEL THERAPEUTICS, INC.$35,667,0003,139,685
+100.0%
4.51%
JNCE  JOUNCE THERAPEUTICS, INC.$31,311,000
+46.7%
3,048,7800.0%3.96%
+116.1%
VYGR  VOYAGER THERAPEUTICS, INC.$30,102,000
-34.1%
6,391,1760.0%3.81%
-3.0%
RLAY ExitRELAY THERAPEUTICS, INC.$0-10,551,115
-100.0%
-37.66%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

  • Mark Levin #1
  • Kevin P. Starr #2
  • Robert I. Tepper #3
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-05-12
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
VOYAGER THERAPEUTICS, INC.22Q1 202374.0%
JOUNCE THERAPEUTICS, INC.20Q3 202224.5%
PLIANT THERAPEUTICS, INC.14Q3 2023100.0%
FULCRUM THERAPEUTICS, INC.14Q4 202243.8%
REVOLUTION MEDICINES, INC.12Q4 202253.8%
DECIBEL THERAPEUTICS, INC.10Q2 202366.3%
NEON THERAPEUTICS, INC.8Q1 202041.1%
NURIX THERAPEUTICS, INC.8Q2 202217.7%
RELAY THERAPEUTICS, INC.2Q4 202037.7%
MYOKARDIA, INC.2Q1 201822.1%

View TRV GP III, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-13
13F-HR2023-08-10
13F-HR2023-05-12
13F-HR2023-02-14
42023-02-06
42023-02-01
42023-01-31
42023-01-26
42023-01-24

View TRV GP III, LLC's complete filings history.

Compare quarters

Export TRV GP III, LLC's holdings